CTSO

CytoSorbents Corporation (NASDAQ:CTSO) is a medical device company founded in 1997 and headquartered in Princeton, New Jersey. The company specializes in blood purification technology, developing and commercializing medical devices that remove harmful substances from blood during critical care situations. Originally incorporated as MedaSorb Technologies Corporation, the company changed its name to CytoSorbents Corporation in May 2010 and went public in 2006. Today, CytoSorbents operates primarily in international markets with over 270,000 of its flagship devices used across 70+ countries, while pursuing regulatory approval to enter the lucrative U.S. healthcare market.